Veterinary medicines European public assessment report (EPAR): Eryseng, Erysipelothrix rhusiopathiae, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Eryseng, Erysipelothrix rhusiopathiae, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Eryseng, Erysipelothrix rhusiopathiae, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Eryseng Parvo, porcine parvovirus and Erysipelothrix rhusiopathiae, Status: Authorised
Portfolio and technology meeting briefing document
Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 09:00 (CEST) to 24 September 2025, 16:10 (CEST)
Patients and Consumers Working Party (PCWP) plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 08:45 (CEST) to 23 September 2025, 12:00 (CEST)
HCPWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 14:00 (CEST) to 23 September 2025, 17:30 (CEST)
Clozapine
PSUSA/00010402/202501
PSUSA/00001999/202501
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Withdrawn